Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2022 | 4 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Therapeutic synergy of Triptolide and MDM2 inhibitor against acute myeloid leukemia through modulation of p53-dependent and -independent pathways.
Exp Hematol Oncol. 2022 Apr 16;11(1):23. doi: 10.1186/s40164-022-00276-z.
Exp Hematol Oncol. 2022.
PMID: 35429966
Free PMC article.
Preclinical Evaluation of the Multiple Tyrosine Kinases Inhibitor Anlotinib in Leukemia Stem Cells.
Jiang Y, Liu L, Jiang Y, Li Z, Feng L, Zhuang X, Lin Z, Chen Q, Chen G, He J, Li G, Zha J, Xu B.
Jiang Y, et al.
Pharmaceuticals (Basel). 2022 Oct 25;15(11):1313. doi: 10.3390/ph15111313.
Pharmaceuticals (Basel). 2022.
PMID: 36355485
Free PMC article.
Item in Clipboard
Apatinib exhibits anti-leukemia activity in preclinical models of acute lymphoblastic leukemia.
Deng M, Zha J, Jiang Z, Jia X, Shi Y, Li P, Chen XL, Fang Z, Du Z, Xu B.
Deng M, et al.
J Transl Med. 2018 Feb 28;16(1):47. doi: 10.1186/s12967-018-1421-y.
J Transl Med. 2018.
PMID: 29490645
Free PMC article.
Item in Clipboard
Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid Leukemia by Inhibiting MEK/ERK and p38-MAPK Signaling Pathways.
Li G, Yao J, Lu Z, Yu L, Chen Q, Ding L, Fang Z, Li Y, Xu B.
Li G, et al.
Drugs R D. 2023 Dec;23(4):439-451. doi: 10.1007/s40268-023-00442-6. Epub 2023 Oct 17.
Drugs R D. 2023.
PMID: 37847357
Free PMC article.
Item in Clipboard
Adverse events in lymphoma patients treated with phosphoinositide 3 kinase Inhibitor in clinical trials: a meta-analysis.
Shan W, Wu G, Huang Y, Zeng H, Xia W, Lin Z, Xu B.
Shan W, et al.
Ann Hematol. 2022 Aug;101(8):1741-1753. doi: 10.1007/s00277-022-04876-x. Epub 2022 Jun 11.
Ann Hematol. 2022.
PMID: 35688904
Item in Clipboard
Pharmacological targeting PIKfyve and tubulin as an effective treatment strategy for double-hit lymphoma.
Feng L, Chen K, Huang W, Jiang Y, Sun X, Zhou Y, Li L, Li Y, Deng X, Xu B.
Feng L, et al.
Cell Death Discov. 2022 Jan 28;8(1):39. doi: 10.1038/s41420-022-00833-9.
Cell Death Discov. 2022.
PMID: 35091546
Free PMC article.
Item in Clipboard
Cite
Cite